Investigating colonic lymphatic endothelial cell (LEC) heterogeneity in homeostasis and disease pathogenesis 3727

Description The pathophysiology of ulcerative colitis (UC) is driven by a disrupted intestinal barrier that triggers aberrant immune responses to gut commensal microbes. The lymphatic vasculature is critical for maintaining intestinal immune homeostasis, and lymphatic expansion is a hallmark of UC pathology. However, the molecular drivers and functional consequences of increased lymphangiogenesis remain unclear. During development, PROX1+/LYVE1+ lymphatic endothelial cell (LEC) progenitors originating from the cardinal vein form a mature lymphatic network through sprouting lymphangiogenesis. We recently showed that lymphatic vessels in the colonic mucosa run along the base of the crypts, extending into individual mucosal folds, and begin developing shortly after birth. High resolution imaging of colons from newborn pups revealed PROX1+/LYVE1+ mesenteric lymphatic vessels beginning to invade the wall of the colon and several individual PROX1+/LYVE1- LECs dispersed throughout the mucosa. By day 2, these LECs appeared near the growing mucosal fold lymphatics extending from the mesentery. These data suggest that the colon LECs are heterogenous in origin and we hypothesize that the distinct LEC populations exhibit unique spatial patterns, gene expression and functions in the colon. This study aims to describe the functional consequences of colonic LEC heterogeneity under homeostatic and inflammatory conditions with the goal of identifying new therapeutic targets for treatment of UC. Funding Sources NIH NIAD grant U01AI163064 Topic Categories Mucosal and Regional Immunology (MUC)